1Cademy - Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination

Concept

Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination

Took a random sample of eligible patients, stratified by hospital
25 hospitals in New York City metropolitan area were selected by having a “high-volume” of COVID-19 cases, defined as 45 discharges during the sampling period
Patients were eligible if admitted to one of these hospitals for at least 24 hours between March 15 and March 28, 2020 and tested positive for SARS-CoV-2

0

1

Updated 2020-05-25

Contributors are:

Who are from:

References